Search by Drug Name or NDC

    NDC 52083-0623-01 Tusslin 7.5; 88; 2.5 mg/mL; mg/mL; mg/mL Details

    Tusslin 7.5; 88; 2.5 mg/mL; mg/mL; mg/mL

    Tusslin is a ORAL SOLUTION/ DROPS in the HUMAN OTC DRUG category. It is labeled and distributed by Kramer Novis. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 52083-0623
    Product ID 52083-623_a5539e41-632f-4d48-8a49-1d93e5c531be
    Associated GPIs 43997303100945
    GCN Sequence Number 065717
    GCN Sequence Number Description guaifen/dextromethorphan/PE LIQUID 7.5-2.5/ML ORAL
    HIC3 B4R
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-EXPECTORANT
    GCN 27748
    HICL Sequence Number 000216
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR/PHENYLEPHRINE
    Brand/Generic Generic
    Proprietary Name Tusslin
    Proprietary Name Suffix Pediatric
    Non-Proprietary Name Dextromethorphan Hbr, Guiafenesin, Phenylephrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION/ DROPS
    Route ORAL
    Active Ingredient Strength 7.5; 88; 2.5
    Active Ingredient Units mg/mL; mg/mL; mg/mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Kramer Novis
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 52083-0623-01 (52083062301)

    NDC Package Code 52083-623-01
    Billing NDC 52083062301
    Package 30 mL in 1 BOTTLE, DROPPER (52083-623-01)
    Marketing Start Date 2014-01-27
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 6fe91407-08c1-465b-9c00-251c94b1f7f0 Details

    Revised: 9/2019